Correction: MiR-29b-3p inhibits migration and invasion of papillary thyroid carcinoma by down-regulating COL1A1 and COL5A1
Congjun Wang, Ye Wang, Zhao Fu, Weijia Huang, Zhu Yu, Jiancheng Wang, Kaitian Zheng, Siwen Zhang, Shen Li, Junqiang Chen
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCircular RNAs in diseases · Cancer, Lipids, and Metabolism · S100 Proteins and Annexins
In the published article, there was an error in Figure 2 as published. In Figure 2E, the EDU experimental result images for the B-CPAP cell line NC inhibitor treatment group were misplaced. The corrected Figure 2 and its caption appear below.
In the published article, there was an error in Figure 4 as published. In Figure 4N, image arrangement errors occurred for the K1 cell line miR-29b-3p Mimic treatment group and the B-CPAP cell line NC Mimic, miR-29b-3p Mimic, and miR-29b-3p Mimic + OE COL5A1 treatment groups. The corrected Figure 4 and its caption appear below.
In the published article, there was an error in Figure 5 as published. In Figure 5L, the immunofluorescence experimental result images for the B-CPAP cell line si-COL1A1–2 treatment group were misplaced during assembly. The corrected Figure 5 and its caption appear below.
The original version of this article has been updated.